Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population.

Binary Cancer screening General health Non-binary Prevention Transgender

Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
11 May 2024
Historique:
received: 20 12 2023
accepted: 09 03 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: aheadofprint

Résumé

Information on the general health of transgender and gender diverse (TGD) individuals continues to be lacking. To bridge this gap, the National Institute of Health in Italy together with the National Office against Racial Discriminations, clinical centres, and TGD organizations carried out a cross-sectional study to define the sociodemographic profile, health-related behaviours, and experiences of healthcare access in Italian TGD adult population. A national survey was conducted by Computer-Assisted Web Interviewing (CAWI) technique. Collected data were compared within the TGD subgroups and between TGD people and the Italian general population (IGP). TGD respondents were 959: 65% assigned female at birth (AFAB) and 35% assigned male at birth (AMAB). 91.8% and 8.2% were binary and non-binary TGD respondents, respectively. More than 20% of the TGD population reported to be unemployed with the highest rate detectable in AMAB and non-binary people. Cigarette smoking and binge drinking were higher in the TGD population compared with IGP (p < 0.05), affecting TGD subgroups differently. A significant lower percentage of AFAB TGD people reported having had screening for cervical and breast cancer in comparison with AFAB IGP (p < 0.0001, in both cases). Over 40% was the percentage of AFAB and non-binary TGD people accessing healthcare who felt discriminated against because of their gender identity. Our results are a first step towards a better understanding of the health needs of TGD people in Italy in order to plan the best policy choices for a more inclusive public health.

Identifiants

pubmed: 38733428
doi: 10.1007/s40618-024-02362-x
pii: 10.1007/s40618-024-02362-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Références

Coleman E, Radix AE, Bouman WP et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 23(Suppl 1):S1–S259. https://doi.org/10.1080/26895269.2022.2100644
doi: 10.1080/26895269.2022.2100644 pubmed: 36238954 pmcid: 9553112
Zhang Q, Goodman M, Adams N et al (2020) Epidemiological considerations in transgender health: a systematic review with focus on higher quality data. Int J Transgend Health 21(2):125–137. https://doi.org/10.1080/26895269.2020.1753136
doi: 10.1080/26895269.2020.1753136 pubmed: 33015664 pmcid: 7430478
Fisher A, Marconi M, Castellini G et al (2024) Estimate and needs of the transgender adult population in Italy: the spot study. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02251-9
doi: 10.1007/s40618-023-02251-9 pubmed: 38372939
Wiepjes CM, Nota NM, de Blok CJM et al (2018) The amsterdam cohort of gender dysphoria study (1972–2015): trends in prevalence, treatment, and regrets. J Sex Med 15(4):582–590. https://doi.org/10.1016/j.jsxm.2018.01.016
doi: 10.1016/j.jsxm.2018.01.016 pubmed: 29463477
Leinung MC, Joseph J (2020) Changing demographics in transgender individuals seeking hormonal therapy: are trans women more common than trans men? Transgend Health 5(4):241–245. https://doi.org/10.1089/trgh.2019.0070
doi: 10.1089/trgh.2019.0070 pubmed: 33644314 pmcid: 7906237
Reisner SL, Poteat T, Keatley J et al (2016) Global health burden and needs of transgender populations: a review. Lancet 388(10042):412–436. https://doi.org/10.1016/S0140-6736(16)00684-X
doi: 10.1016/S0140-6736(16)00684-X pubmed: 27323919 pmcid: 7035595
Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, Wylie K (2016) Transgender people: health at the margins of society. Lancet 388(10042):390–400. https://doi.org/10.1016/S0140-6736(16)00683-8
doi: 10.1016/S0140-6736(16)00683-8 pubmed: 27323925
EU Agency for Fundamental Rights (2020) A long way to go for LGBTI equality: technical report. Luxembourg. https://fra.europa.eu/sites/default/files/fra_uploads/fra-2020-lgbti-equality-technical-report_en.pdf . Accessed 7 Dec 2022
Reisner SL, Deutsch MB, Bhasin S et al (2016) Advancing methods for US transgender health research. Curr Opin Endocrinol Diabetes Obes 23(2):198–207. https://doi.org/10.1097/MED.0000000000000229
doi: 10.1097/MED.0000000000000229 pubmed: 26845331 pmcid: 4916925
ISTAT, Istituto Nazionale di Statistica (2017) Forme, livelli e dinamiche dell’urbanizzazione in Italia. https://www.istat.it/it/files/2017/05/Urbanizzazione.pdf . Accessed 7 Dec 2022
National health service: essential levels of assistance. Preventive healthcare measures. https://www.salute.gov.it/portale/lea/dettaglioContenutiLea.jsp?lingua=english&id=5442&area=Lea&menu=prevLea . Accessed 7 Dec 2022
Distante V, Ciatto S, Frigerio A et al (2007) Recommendations of a national Italian consensus conference on the opportunity of extending screening service by mammography to 40–49 and 70–74 years of age women. Epidemiol Prev 31(1):15–22
pubmed: 17591400
ISTAT, Istituto Nazionale di Statistica. Resident population on 1st January 2021. https://esploradati.istat.it/databrowser/#/it/dw/categories/IT1,POP,1.0/POP_POPULATION/DCIS_POPRES1/IT1,22_289_DF_DCIS_POPRES1_1,1.0 . Accessed 7 Dec 2022
Fisher AD, Bandini E, Casale H et al (2013) Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med 10(2):408–419. https://doi.org/10.1111/j.1743-6109.2012.03006.x
doi: 10.1111/j.1743-6109.2012.03006.x pubmed: 23171237
Baldissera S, Ferrante G, Quarchioni E et al (2014) Field substitution of nonresponders can maintain sample size and structure without altering survey estimates-the experience of the Italian behavioral risk factors surveillance system (PASSI). Ann Epidemiol 24(4):241–245. https://doi.org/10.1016/j.annepidem.2013.12.003
doi: 10.1016/j.annepidem.2013.12.003 pubmed: 24461932
Baldissera S, Campostrini S, Binkin N et al (2011) Features and initial assessment of the Italian behavioral risk factor surveillance system (PASSI), 2007–2008. Prev Chronic Dis 8(1):A24
pubmed: 21159236
Romani A, Mazzoli F, Ristori J et al (2021) Psychological wellbeing and perceived social acceptance in gender diverse individuals. J Sex Med 18(11):1933–1944. https://doi.org/10.1016/j.jsxm.2021.08.012
doi: 10.1016/j.jsxm.2021.08.012 pubmed: 34749989
Leppel K (2021) Transgender men and women in 2015: employed, unemployed, or not in the labor force. J Homosex 68(2):203–229. https://doi.org/10.1080/00918369.2019.1648081
doi: 10.1080/00918369.2019.1648081 pubmed: 31403900
Aparicio-García ME, Díaz-Ramiro EM, Rubio-Valdehita S, López-Núñez MI, García-Nieto I (2018) Health and well-being of cisgender transgender and non-binary young people. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph15102133
doi: 10.3390/ijerph15102133 pubmed: 30274141 pmcid: 6209926
Azagba S, Latham K, Shan L (2019) Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States. Int J Drug Policy 73:163–169. https://doi.org/10.1016/j.drugpo.2019.07.024
doi: 10.1016/j.drugpo.2019.07.024 pubmed: 31353246
Buchting FO, Emory KT, Scout KY, Fagan P, Vera LE, Emery S (2017) Transgender use of cigarettes, cigars, and E-cigarettes in a national study. Am J Prev Med 53(1):e1–e7. https://doi.org/10.1016/j.amepre.2016.11.022
doi: 10.1016/j.amepre.2016.11.022 pubmed: 28094133 pmcid: 5478444
Tamí-Maury I, Sharma A, Chen M, Blalock J, Ortiz J, Weaver L, Shete S (2020) Comparing smoking behavior between female-to-male and male-to-female transgender adults. Tob Prev Cessat. https://doi.org/10.18332/tpc/114513
doi: 10.18332/tpc/114513 pubmed: 32548339 pmcid: 7291890
Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK (2021) Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults. JAMA Netw Open 4(2):e2036512. https://doi.org/10.1001/jamanetworkopen.2020.36512
doi: 10.1001/jamanetworkopen.2020.36512 pubmed: 33538824 pmcid: 7862992
Kittaneh AA, Patel S, Sidhu NK, Lechner WV, Kenne DR (2021) Tobacco use status as a function of transgender identity: the mediating role of psychological distress. Tob Use Insights 14:1179173X211004267. https://doi.org/10.1177/1179173X211004267
doi: 10.1177/1179173X211004267 pubmed: 33854393 pmcid: 8013634
Downing JM, Przedworski JM (2018) Health of transgender adults in the U.S., 2014–2016. Am J Prev Med 55(3):336–344. https://doi.org/10.1016/j.amepre.2018.04.045
doi: 10.1016/j.amepre.2018.04.045 pubmed: 30031640
Sawyer AN, Bono RS, Kaplan B, Breland AB (2022) Nicotine/tobacco use disparities among transgender and gender diverse adults: findings from wave 4 PATH data. Drug Alcohol Depend 232:109268. https://doi.org/10.1016/j.drugalcdep.2022.109268
doi: 10.1016/j.drugalcdep.2022.109268 pubmed: 35038608 pmcid: 8885914
Mahalik JR, Burns SM, Syzdek M (2007) Masculinity and perceived normative health behaviors as predictors of men’s health behaviors. Soc Sci Med 64(11):2201–2209. https://doi.org/10.1016/j.socscimed.2007.02.035
doi: 10.1016/j.socscimed.2007.02.035 pubmed: 17383784
Wheldon CW, Watson RJ, Fish JN, Gamarel K (2019) Cigarette smoking among youth at the intersection of sexual orientation and gender identity. LGBT Health 6(5):235–241. https://doi.org/10.1089/lgbt.2019.0005
doi: 10.1089/lgbt.2019.0005 pubmed: 31140928 pmcid: 6909748
Coulter RW, Blosnich JR, Bukowski LA, Herrick AL, Siconolfi DE, Stall RD (2015) Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults. Drug Alcohol Depend 154:251–259. https://doi.org/10.1016/j.drugalcdep.2015.07.006
doi: 10.1016/j.drugalcdep.2015.07.006 pubmed: 26210734 pmcid: 4536098
Day JK, Fish JN, Perez-Brumer A, Hatzenbuehler ML, Russell ST (2017) Transgender youth substance use disparities: results from a population-based sample. J Adolesc Health 61(6):729–735. https://doi.org/10.1016/j.jadohealth.2017.06.024
doi: 10.1016/j.jadohealth.2017.06.024 pubmed: 28942238 pmcid: 6802742
Reisner SL, Greytak EA, Parsons JT, Ybarra ML (2015) Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity. J Sex Res 52(3):243–256. https://doi.org/10.1080/00224499.2014.886321
doi: 10.1080/00224499.2014.886321 pubmed: 24742006
Gamarel KE, Mereish EH, Manning D, Iwamoto M, Operario D, Nemoto T (2016) Minority stress, smoking patterns, and cessation attempts: findings from a community-sample of transgender women in the san francisco bay area. Nicotine Tob Res 18(3):306–313. https://doi.org/10.1093/ntr/ntv066
doi: 10.1093/ntr/ntv066 pubmed: 25782458
Shires DA, Jaffee KD (2016) Structural discrimination is associated with smoking status among a national sample of transgender individuals. Nicotine Tob Res 18(6):1502–1508. https://doi.org/10.1093/ntr/ntv221
doi: 10.1093/ntr/ntv221 pubmed: 26438646
Hatzenbuehler ML, Phelan JC, Link BG (2013) Stigma as a fundamental cause of population health inequalities. Am J Public Health 103(5):813–821. https://doi.org/10.2105/AJPH.2012.301069
doi: 10.2105/AJPH.2012.301069 pubmed: 23488505 pmcid: 3682466
de Blok CJM, Dreijerink KMA, den Heijer M (2019) Cancer risk in transgender people. Endocrinol Metab Clin North Am 48(2):441–452. https://doi.org/10.1016/j.ecl.2019.02.005
doi: 10.1016/j.ecl.2019.02.005 pubmed: 31027551
Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M (2017) Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev 39(1):93–107. https://doi.org/10.1093/epirev/mxw003
doi: 10.1093/epirev/mxw003 pubmed: 28486701 pmcid: 5868281
Leone AG, Casolino R, Trapani D et al (2023) Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the assisi recommendations. EClinicalMedicine 65:102277. https://doi.org/10.1016/j.eclinm.2023.102277
doi: 10.1016/j.eclinm.2023.102277 pubmed: 37877000 pmcid: 10590834
Bazzi AR, Whorms DS, King DS, Potter J (2015) Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health 105(11):2356–2358. https://doi.org/10.2105/AJPH.2015.302851
doi: 10.2105/AJPH.2015.302851 pubmed: 26378843 pmcid: 4605197
Luehmann N, Ascha M, Chwa E et al (2022) A single-center study of adherence to breast cancer screening mammography guidelines by transgender and non-binary patients. Ann Surg Oncol 29(3):1707–1717. https://doi.org/10.1245/s10434-021-10932-z
doi: 10.1245/s10434-021-10932-z pubmed: 34704183
Tabaac AR, Sutter ME, Wall CSJ, Baker KE (2018) Gender identity disparities in cancer screening behaviors. Am J Prev Med 54(3):385–393. https://doi.org/10.1016/j.amepre.2017.11.009
doi: 10.1016/j.amepre.2017.11.009 pubmed: 29338956
Kiran T, Davie S, Singh D, Hranilovic S, Pinto AD, Abramovich A, Lofters A (2019) Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician 65(1):e30–e37
pubmed: 30674526 pmcid: 6347308
Scheim A, Bauer G (2013) Breast and cervical cancer screening among trans Ontarians: a report prepared for the Screening Saves Lives Program of the Canadian Cancer Society. Trans PULSE Project. https://www.transpulseproject.ca . Accessed 7 Dec 2022
Heer E, Peters C, Knight R, Yang L, Heitman SJ (2023) Participation, barriers, and facilitators of cancer screening among LGBTQ+ populations: a review of the literature. Prev Med 170:107478. https://doi.org/10.1016/j.ypmed.2023.107478
doi: 10.1016/j.ypmed.2023.107478 pubmed: 36921771
Peitzmeier SM, Agénor M, Bernstein IM et al (2017) “It can promote an existential crisis”: Factors influencing pap test acceptability and utilization among transmasculine individuals. Qual Health Res 27(14):2138–2149. https://doi.org/10.1177/1049732317725513
doi: 10.1177/1049732317725513 pubmed: 28836483
Peitzmeier SM, Khullar K, Reisner SL, Potter J (2014) Pap test use is lower among female-to-male patients than non-transgender women. Am J Prev Med 47(6):808–812. https://doi.org/10.1016/j.amepre.2014.07.031
doi: 10.1016/j.amepre.2014.07.031 pubmed: 25455121
James SEHJ, Rankin S, Keisling M, Mottet LAA (2016) The report of the 2015 US Transgender Survey. https://www.ustranssurvey.org/reports . Accessed 7 Dec 2022
Agénor M, White Hughto JM, Peitzmeier SM, Potter J, Deutsch MB, Pardee DJ, Reisner SL (2018) Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults. J Gen Intern Med 33(7):1015–1017. https://doi.org/10.1007/s11606-018-4400-3
doi: 10.1007/s11606-018-4400-3 pubmed: 29654599 pmcid: 6025652
Carroll R, Tan KKH, Ker A, Byrne JL, Veale JF (2023) Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand. Aust N Z J Obstet Gynaecol 63(3):448–453. https://doi.org/10.1111/ajo.13674
doi: 10.1111/ajo.13674 pubmed: 37005094
Agénor M, Peitzmeier SM, Bernstein IM et al (2016) Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Cult Health Sex 18(10):1192–1206. https://doi.org/10.1080/13691058.2016.1177203
doi: 10.1080/13691058.2016.1177203 pubmed: 27142466
Nicholls EJ, McGowan CR, Miles S et al (2023) Provision of cervical screening for transmasculine patients: a review of clinical and programmatic guidelines. BMJ Sex Reprod Health 49(2):118–128. https://doi.org/10.1136/bmjsrh-2022-201526
doi: 10.1136/bmjsrh-2022-201526 pubmed: 36344235
Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS (2023) Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract OP2200681. https://doi.org/10.1200/OP.22.00681
doi: 10.1200/OP.22.00681
Scheim AI, Perez-Brumer AG, Bauer GR (2020) Gender-concordant identity documents and mental health among transgender adults in the USA: a cross-sectional study. Lancet Public Health 5(4):e196–e203. https://doi.org/10.1016/S2468-2667(20)30032-3
doi: 10.1016/S2468-2667(20)30032-3 pubmed: 32192577 pmcid: 9912749
Kattari SK, Call J, Holloway BT, Kattari L, Seelman KL (2021) Exploring the experiences of transgender and gender diverse adults in accessing a trans knowledgeable primary care physician. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph182413057
doi: 10.3390/ijerph182413057 pubmed: 34948676 pmcid: 8701045
Drabish K, Theeke LA (2022) Health impact of stigma, discrimination, prejudice, and bias experienced by transgender people: a systematic review of quantitative studies. Issues Ment Health Nurs 43(2):111–118. https://doi.org/10.1080/01612840.2021.1961330
doi: 10.1080/01612840.2021.1961330 pubmed: 34469283
Jaffee KD, Shires DA, Stroumsa D (2016) Discrimination and delayed health care among transgender women and men: implications for improving medical education and health care delivery. Med Care 54(11):1010–1016. https://doi.org/10.1097/MLR.0000000000000583
doi: 10.1097/MLR.0000000000000583 pubmed: 27314263
de Vries E, Kathard H, Müller A (2020) Debate: Why should gender-affirming health care be included in health science curricula? BMC Med Educ 20(1):51. https://doi.org/10.1186/s12909-020-1963-6
doi: 10.1186/s12909-020-1963-6 pubmed: 32059721 pmcid: 7023748
Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J (2016) Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes 23(2):168–171. https://doi.org/10.1097/MED.0000000000000227
doi: 10.1097/MED.0000000000000227 pubmed: 26910276 pmcid: 4802845
Feldman JL, Luhur WE, Herman JL, Poteat T, Meyer IH (2021) Health and health care access in the US transgender population health (TransPop) survey. Andrology 9(6):1707–1718. https://doi.org/10.1111/andr.13052
doi: 10.1111/andr.13052 pubmed: 34080788 pmcid: 8613303
National Academies of Sciences, Engineering, and Medicine (2020) Understanding the Well-Being of LGBTQI+ Populations. The National Academies Press, Washington, DC. https://doi.org/10.17226/25877

Auteurs

M Marconi (M)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

M T Pagano (MT)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

J Ristori (J)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.

S Bonadonna (S)

Istituto Auxologico Italiano, IRCCS, Milan, Italy.

R Pivonello (R)

Dipartimento Di Medicina Clinica E Chirurgia, Sezione di Endocrinologia, University Federico II, Naples, Italy.

M C Meriggiola (MC)

Division of Gynecology and Physiopathology of Human Reproduction, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, University of Bologna, Bologna, Italy.

G Motta (G)

Division of Endocrinology, Diabetology and Metabolism, Azienda Ospedaliero-Universitaria Città Della Salute E Della Scienza di Torino, University of Turin, Turin, Italy.

F Lombardo (F)

Laboratory of Semiology, Department of Experimental Medicine, Sperm Bank "Loredana Gandini", Sapienza University of Rome, Rome, Italy.

M Mosconi (M)

Gender Identity Development Service, Hospital S. Camillo-Forlanini, Rome, Italy.

A Oppo (A)

Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

C Cocchetti (C)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.

A Romani (A)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.

S Federici (S)

Istituto Auxologico Italiano, IRCCS, Milan, Italy.

L Bruno (L)

Dipartimento Di Medicina Clinica E Chirurgia, Sezione di Endocrinologia, University Federico II, Naples, Italy.

N Verde (N)

Dipartimento Di Medicina Clinica E Chirurgia, Sezione di Endocrinologia, University Federico II, Naples, Italy.

A Lami (A)

Division of Gynecology and Physiopathology of Human Reproduction, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, University of Bologna, Bologna, Italy.

C M Crespi (CM)

Division of Endocrinology, Diabetology and Metabolism, Azienda Ospedaliero-Universitaria Città Della Salute E Della Scienza di Torino, University of Turin, Turin, Italy.

L Marinelli (L)

Division of Endocrinology, Diabetology and Metabolism, Azienda Ospedaliero-Universitaria Città Della Salute E Della Scienza di Torino, University of Turin, Turin, Italy.

L Giordani (L)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

P Matarrese (P)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

A Ruocco (A)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

C Santangelo (C)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

B Contoli (B)

National Centre for Disease Prevention and Health Promotion, Istituto Superiore Di Sanità, Rome, Italy.

M Masocco (M)

National Centre for Disease Prevention and Health Promotion, Istituto Superiore Di Sanità, Rome, Italy.

V Minardi (V)

National Centre for Disease Prevention and Health Promotion, Istituto Superiore Di Sanità, Rome, Italy.

F Chiarotti (F)

Reference Centre for Behavioral Sciences and Mental Health, Istituto Superiore Di Sanità, Rome, Italy.

A D Fisher (AD)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.

M Pierdominici (M)

Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy. marina.pierdominici@iss.it.

Classifications MeSH